Westwicke is an IPO advisory, capital markets advisory, and strategic communications firm. We provide integrated investor relations, public relations, and independent capital markets advice to small and mid-cap healthcare companies.
We work with private and public healthcare companies to help position their story properly with all critical stakeholders and to develop value-added strategies to build brand awareness, corporate reputation and enhance equity market value. Through an integrated approach, we provide a one-stop-shop for the full spectrum of communications needs across the entire corporate lifecycle from early stage start-up to mature public company.
Our background is unique. Our investor relations partners all come directly from Wall Street as former sell-side research analysts, institutional salesmen, investment bankers, equity capital markets professionals, buy-side analysts and portfolio managers, while our public relations team are former agency veterans, corporate communications executives and journalists.
Latest Blog Posts
September 23rd, 2021
The biotech market has been growing rapidly over the past two decades, and is expected to be worth nearly $2.5 trillion by 2028. Meanwhile, the pace of technological developments and innovation have reduced barriers to entry, leading to an influx of aspiring biotech startups eager to bring their products to market. But despite the increase […]
September 7th, 2021
Biotech and biopharma investors are picky: such companies are risky and there are plenty to choose from. Here are 10 items you must address in your IR plan.
August 24th, 2021
Just as schools and businesses run occasional fire drills, your company should periodically pressure test your crisis communications plan. To truly understand if and how the plan will work, your management team and employees need to see how your strategy will play out in a realistic scenario.